Asset Details
Do you wish to reserve the book?
Editorial: The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Editorial: The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies
Do you wish to request the book?
Editorial: The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Editorial: The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies
2022
Overview
[...]there are many promising preclinical and trials data in NSCLC, where in parallel with classical ICIs targeting PD-1/PD-L1, new target molecules could be used, such as: [...]they shed new light on the possibility of administering fecal microbiota transplantation to modulate the gut microbiota in cancer treatment. The ICP score showed reliability and efficacy in predicting the survival of patients with gliomas, in pan-cancer samples, and six independent cancer types. [...]the ICP score was correlated with the genomic alteration features in gliomas, exhibited a remarkable association with multiple immunomodulators that could potentially mediate immune escape, and predicted immunotherapeutic responses with a high sensitivity.
We currently cannot retrieve any items related to this title. Kindly check back at a later time.